Humedix Co., Ltd. (KOSDAQ: 200670)

Market Cap	355.51B
Revenue (ttm)	110.99B
Net Income (ttm)	9.06B
Shares Out	10.40M
EPS (ttm)	963.99
PE Ratio	35.48
Forward PE	8.16
Dividend	550.00 (1.69%)
Ex-Dividend Date	Jun 27, 2024

Volume	441,442
Open	33,300
Previous Close	32,500
Day's Range	33,250 - 36,400
52-Week Range	26,750 - 41,350
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.